Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Edge Cxbladder Monitor

Pacific Edge has launched the Cxbladder Monitor, a urine-based gene expression test for investigation of bladder cancer in patients being monitored for recurrent disease. The test analyzes urine samples for expression genes, clinical, and patient variable factors that create unique molecular signatures for urothelial carcinoma. It is designed to be used on patients undergoing bladder cancer surveillance to determine if they have a low probability of having recurrence.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.